American Journal of Drug and Alcohol Abuse is a highly regarded publication in the field of substance abuse research, published by Taylor & Francis Inc. With its inception in 1974, this journal has become an essential resource for scholars and practitioners interested in clinical psychology, psychiatry, and the multifaceted issues surrounding drug and alcohol use. It holds a notable Q2 ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, emphasizing its impact and relevance in these domains. The journal's 2023 Scopus rankings further highlight its standing, placing it in the top quartile of publications with established readership and citation metrics. Researchers and students can benefit from its comprehensive articles that delve into the complexities of substance use, treatment methodologies, and the socio-psychological underpinnings of addiction. Whether you seek to access cutting-edge studies or contribute to ongoing discourse in the field, the American Journal of Drug and Alcohol Abuse serves as a vital hub for knowledge dissemination and scholarly engagement.

The Journal of the International AIDS Society, published by John Wiley & Sons Ltd, stands as a premier platform for advancing knowledge in the realms of infectious diseases and public health, boasting a strong Q1 ranking in both categories as of 2023. With its open-access format established since 2004, the journal ensures that groundbreaking research on HIV/AIDS and related issues is widely disseminated and easily accessible to a global audience. This commitment to accessibility significantly enhances its impact factor, making it a vital resource for researchers, practitioners, and students alike who are dedicated to improving health outcomes and understanding the complexities of the epidemic. Covering a diverse range of topics from prevention strategies to health policy, the journal supports its readers in staying at the forefront of public health discourse. With its base in the United States and an impressive Scopus ranking placing it within the top tiers of medical publications, the Journal of the International AIDS Society continues to foster collaboration and innovation in the fight against HIV/AIDS.

Preventive Medicine Reports is a premier open-access journal published by Elsevier, dedicated to advancing the field of preventive medicine and public health. With a focus on innovative research and practices since its inception in 2014, this journal has established itself in the top quartile (Q1) of both Health Informatics and Public Health, Environmental and Occupational Health categories as of 2023. This positions it among the leading publications in its field, showcasing significant contributions to health informatics and public health strategies. The journal's accessibility allows researchers, professionals, and students worldwide to engage with cutting-edge studies that inform health policy and preventive initiatives. By fostering an open exchange of knowledge, Preventive Medicine Reports aims to reduce health disparities and improve population health outcomes, making it an essential resource for anyone invested in the future of health sciences.

AIDS Research and Therapy is a prestigious peer-reviewed journal dedicated to disseminating cutting-edge research in the fields of AIDS and HIV therapy. Published by BMC, this Open Access journal has been freely available since its inception in 2004, facilitating global access to vital research findings. Based in the United Kingdom, the journal covers a diverse range of topics including molecular medicine, pharmacology, and virology, making it a crucial resource for researchers and clinicians alike. Recognized for its strong impact within the scientific community, it holds a Q2 quartile ranking in multiple categories as of 2023, including Molecular Medicine and Pharmacology. With an aim to enhance understanding and improve clinical outcomes for those affected by HIV/AIDS, AIDS Research and Therapy serves as an essential platform for the exchange of innovative ideas and practices that can inform future therapies and interventions. Researchers, professionals, and students seeking high-quality, peer-reviewed content will find this journal invaluable in advancing their knowledge and efforts in combating the HIV/AIDS epidemic.

AJAR - African Journal of AIDS Research, an esteemed publication by Taylor & Francis Ltd, stands at the forefront of research in the field of HIV/AIDS, with a specific focus on the African continent. Established in 2003 and publishing continuously through 2024, this journal serves as a crucial platform for disseminating innovative research findings aimed at addressing the challenges of HIV/AIDS. With its ISSN 1608-5906 and E-ISSN 1727-9445, AJAR is indexed in prominent databases and holds a respectable Q3 rating in major categories such as Infectious Diseases, Medicine, Public Health, and Virology as of 2023. This positions the journal as a relevant resource for scholars and medical professionals looking to stay informed on the latest developments and strategies in AIDS research. Although it is not currently an open-access journal, AJAR provides readers with valuable insights that are essential for advancing public health initiatives and infectious disease research across Africa and beyond. The journal's commitment to high-quality peer-reviewed research underscores its importance within its field, making it a vital resource for researchers, students, and policymakers alike.

Asia-Pacific Journal of Public Health, published by SAGE Publications Inc, is a leading platform for disseminating scholarly research in the field of public health. With an impressive scope that spans from the late 1980s to the present, the journal offers a wealth of articles that address critical issues faced by diverse populations in the Asia-Pacific region. Categorized in the Q3 quartile for both Medicine (miscellaneous) and Public Health, Environmental and Occupational Health, it holds a significant position within its field, ranked 310 out of 665 in the Scopus database. Researchers and professionals have access to valuable insights that inform public health policy and practice, making this journal an essential resource for those aiming to enhance health outcomes in the region. While not currently open access, the journal's rigorous peer-review process ensures the integrity and relevance of its content. As the landscape of public health continues to evolve, the Asia-Pacific Journal of Public Health remains a vital resource for advancing knowledge, fostering collaboration, and promoting a healthier society.

Substance Abuse is a premier scholarly journal published by SAGE Publications Inc, dedicated to advancing the understanding and treatment of substance use disorders. With an established presence from 1995 to 2023, the journal boasts an impressive Q1 ranking in both Medicine (miscellaneous) and Psychiatry and Mental Health, positioning it among the top tier of academic publications in these fields. Researchers and professionals will find its articles, which are grounded in rigorous empirical studies and innovative interventions, essential for addressing the complex and multifaceted nature of substance abuse. Although not an open access publication, Substance Abuse maintains a commitment to sharing valuable insights and findings, making it a vital resource for those looking to enhance their knowledge and practice. Located in Thousand Oaks, CA, this journal serves as a critical forum for international dialogue and research dissemination, ensuring that current trends and challenges in substance use are thoughtfully examined and discussed within the academic community.

HIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.

Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.

HIV Research & Clinical Practice, published by Taylor & Francis Ltd, is an essential open-access journal dedicated to advancing the knowledge and understanding of HIV-related research and clinical practices. With an ISSN of 2578-7489 and E-ISSN 2578-7470, this acclaimed journal is committed to disseminating cutting-edge studies and innovative treatment strategies within the infectious diseases and pharmacology fields, achieving a commendable Q2 ranking in both categories as of 2023. The journal's scope encompasses a broad range of topics from basic science to clinical application, providing a vital platform for researchers, clinicians, and students to exchange insights and foster collaboration. As an open-access publication since 2022, it ensures that high-quality research is accessible to a global audience, encouraging a greater understanding of HIV and its implications for public health. With its base in the United Kingdom and a convergence period from 2019 to 2024, HIV Research & Clinical Practice stands at the forefront of the fight against HIV/AIDS, making significant contributions to the clinical community and beyond.